These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 1732707)
1. Hypoglycemic activities of MTP-3631, a novel thiopyranopyrimidine derivative. Ogawa H; Kunoh Y; Sugiura T; Nagasaka M Life Sci; 1992; 50(5):375-81. PubMed ID: 1732707 [TBL] [Abstract][Full Text] [Related]
2. Antidiabetic activity of MTP-3115 in normal and diabetic mice. Yen TT; Dininger NB; Broderick CL; Gill AM Arch Int Pharmacodyn Ther; 1990; 308():137-48. PubMed ID: 2099133 [TBL] [Abstract][Full Text] [Related]
3. Pharmacological studies on the hypoglycemic effect of 7,8-dihydro-2-(4-methylpiperazinyl)-4-(1-pyrrolidinyl)-6H-thi opyrano [3,2-d] pyrimidine dimaleate (MTP-1307), a novel hypoglycemic agent. Kunoh Y; Ogawa H; Nagasaka M; Asai H; Iguchi A; Niki A; Sakamoto N Arch Int Pharmacodyn Ther; 1989; 298():276-87. PubMed ID: 2667487 [TBL] [Abstract][Full Text] [Related]
4. Hypoglycemic activity of MTP-1403 (2-amino-7,8-dihydro-4-piperazinyl-6H-thiopyrano 3,2-d pyrimidine), a new hypoglycemic agent. Kunoh Y; Iguchi A; Gotoh M; Nomura T; Shibata M; Sakamoto N Arch Int Pharmacodyn Ther; 1986 Apr; 280(2):302-13. PubMed ID: 3521517 [TBL] [Abstract][Full Text] [Related]
5. Comparison of McN-3495 [N-(1-methyl-2-pyrrolidinylidene)-N'-phenyl-1-pyrrolidinecarboximidamide], a new, orally effective, hypoglycemic agent, with the biguanides. Tutwiler GF; Bridi G Diabetes; 1978 Aug; 27(8):868-76. PubMed ID: 680413 [No Abstract] [Full Text] [Related]
6. MTP-1307, a novel antidiabetic agent, improves the glucose intolerance of viable yellow obese-diabetic mice. Yen TT Life Sci; 1987 Nov; 41(21):2349-54. PubMed ID: 3683081 [TBL] [Abstract][Full Text] [Related]
7. Effects of new hypoglycemic agent 2-piperazinyl-4-methyl-amino-5-methylthieno [2,3-d]pyrimidine dihydrochloride hydrate. Fujiwara T; Sakamoto Y; Fukasawa I; Horikoshi H; Sugiyama M; Fukumi H Arzneimittelforschung; 1986 Dec; 36(12):1770-4. PubMed ID: 2882759 [TBL] [Abstract][Full Text] [Related]
8. Effect of oral antidiabetics on the anaphylactoid reaction. Wellinger K; Koltai M Acta Physiol Acad Sci Hung; 1981; 58(4):317-9. PubMed ID: 6182744 [TBL] [Abstract][Full Text] [Related]
9. Ciglitazone, a new hypoglycemic agent. I. Studies in ob/ob and db/db mice, diabetic Chinese hamsters, and normal and streptozotocin-diabetic rats. Chang AY; Wyse BM; Gilchrist BJ; Peterson T; Diani AR Diabetes; 1983 Sep; 32(9):830-8. PubMed ID: 6354790 [TBL] [Abstract][Full Text] [Related]
10. Characterization of new oral antidiabetic agent CS-045. Studies in KK and ob/ob mice and Zucker fatty rats. Fujiwara T; Yoshioka S; Yoshioka T; Ushiyama I; Horikoshi H Diabetes; 1988 Nov; 37(11):1549-58. PubMed ID: 3053303 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of centpiperalone in combination with biguanide & sulfonylurea. Srivastava PP; Murthy PS; Mukherjee SK Indian J Exp Biol; 1983 Jul; 21(7):390-2. PubMed ID: 6365752 [No Abstract] [Full Text] [Related]
12. Effects of an alpha 2-adrenoceptor antagonist on glucose tolerance in the genetically obese mouse (C57BL/6J ob/ob). Saperstein R; Chapin EW; Brady EJ; Slater EE Metabolism; 1990 May; 39(5):445-51. PubMed ID: 1970847 [TBL] [Abstract][Full Text] [Related]
13. Effect of oral hypoglycemic drugs on heart norepinephrine (NE) in rats and mice. Anton AH; Berk AI Res Commun Chem Pathol Pharmacol; 1982 Jan; 35(1):79-94. PubMed ID: 7058290 [TBL] [Abstract][Full Text] [Related]
14. Ciglitazone, a new hypoglycemic agent. II. Effect on glucose and lipid metabolisms and insulin binding in the adipose tissue of C57BL/6J-ob/ob and -+/? mice. Chang AY; Wyse BM; Gilchrist BJ Diabetes; 1983 Sep; 32(9):839-45. PubMed ID: 6354791 [TBL] [Abstract][Full Text] [Related]